Membrane Protein Antibody Discovery, MPSA AB5000

De-Risk the off-target interactions of your antibody drug for IND application.

Antibody Discovery Services

MPSA-AB5000 Introduction

The specificity of antibodies, CAR-T cells, and other biologic therapeutics to their binding targets is an important step in the evaluation process of drug development. The lack of suitable methods to identify the targets of functional antibodies and ligands result in drug safety accidents and the abandonment of previous studies.

KYinno’s Membrane Proteins Screening Array (MPSA-AB5000) is an excellent solution for antibody specificity screening which enable early off-target screening and can de-risk the antibody drug development program.

Full Coverage of Human Membrane Protein Library

The MPSA-AB5000 makes use of more than 5000 unique human membrane protein, including receptors, transporters, enzymes, miscellaneous, and others.
Natively expressed in live cells ensuring native protein conformation.

High Sensitivity Reporter System Detection

Wash-free strategy reduces false negatives.
Signal amplification makes large discrimination.
High throughput microplate system guarantees best stability and creditability.

Compatibility with Different Types of Biologic Therapeutics:

MPSA-AB5000 is compatible with monoclonal antibodies, bispecific antibodies, ADC, orphan protein and antibody, as well as CAR-T cell therapies.

Successfully Screened Off-target Molecules

Ultrashort turnaround for data report
Competitively priced

MPSA-AB5000 is rapid, simple and highly sensitive by measuring binding via reporter cell line and can determine specificity and preclinical safety of biotherapeutics conveniently.

All Antibody Discovery Services

BiSpecific Antibodies

Utilizing advanced biotechnology, our engineered bispecific antibodies bind two distinct targets. This innovation has the potential to revolutionize therapeutic strategies, heightening specificity, expanding treatment options, and paving the way for future medical advancements.

Membrane Protein Antibody Discovery, MPS AB5000

Using antibodies with high specificity, we guarantee precise binding targets for CAR-T cells and biologics. This meticulous approach is foundational to therapeutic success and patient outcomes. Promoting next-generation healthcare solutions.

AI Drug Discovery

Nanobodies, known for their small molecular weight, high affinity, stability, permeability, and cost-effectiveness, have demonstrated tremendous potential in disease …